期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Stem Cell Research LetPub Score 7.2
50 ratings
Rate
Reputation 8.3 Influence 6.1 Speed 9.1 | ||||||||||||||||||||||||
期刊簡稱 | STEM CELL RES | ||||||||||||||||||||||||
ISSN | 1873-5061 | ||||||||||||||||||||||||
E-ISSN | 1876-7753 | ||||||||||||||||||||||||
h-index | 55 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 12.50%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.journals.elsevier.com/stem-cell-research/ | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/SCR | ||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | Elsevier | ||||||||||||||||||||||||
主題領域 | 生物 | ||||||||||||||||||||||||
出版國/地區 | NETHERLANDS | ||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||
創刊年 | 2007 | ||||||||||||||||||||||||
每年文章數 | 255每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 95.95% | ||||||||||||||||||||||||
OA Related Info | APC: Yes( USD2210; ) APC waiver:Check Notes Other charges: No Keywords: embryonic stem cells、tissue-specific stem cells、cancer stem cells、developmental studies、stem cell genomes、translational research Useful LinksAims & ScopeAuthor InstructionsEditorial BoardPeer review | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1873-5061%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 3 Month(s) 來自Elsevier的數據: Average 6.8 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 25% | ||||||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 3.1 Week(s) | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Stem Cell Research] 的評論 | 撰寫評論 |
作者: 碧水雅媚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-20 18:20:04 評論於 Research focus: adult stem cells; stem cells; tissue engineering Experience sharing: I gave him a very good review at the beginning, but he didn't want it. Instead, he published on stem cell research and therapy, which has been cited 90 times in less than 2 years. This journal is really going downhill.(0) 讚! | 碧水雅媚 |
作者: 丙申超级甜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-04-26 16:57:18 評論於 How are you? Have you received the article? Will this magazine accept unsolicited submissions?(0) 讚! | 丙申超级甜 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:38:40 評論於 In the field of medicine, most journals and clinical papers highly recommend the use of MeSH. Using MeSH terms can help with literature searches and increase the credibility of publications(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:54:32 評論於 Medical Subject Headings (MeSH) is a metadata system published by the United States National Library of Medicine, widely used in medical information retrieval. It is intended to be used for indexing journal articles and books in the life sciences field. The primary purpose of MeSH is to provide classification for the vast amount of literature in PubMed/MEDLINE(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 15:02:19 評論於 Why should we filter keywords from MeSH?(0) 讚! | 修然小公主 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 14:17:10 評論於 What is MeSH?(0) 讚! | Darlene Pepys |
作者: 北国修洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-08 19:20:04 評論於 Blessings! Accept, accept! ?(0) 讚! | 北国修洁 |
作者: 云来啸垄 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-09-24 19:31:36 評論於 Received(0) 讚! | 云来啸垄 |
作者: 云来啸垄 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-06-29 15:17:23 評論於 Have you been in contact with the editor all this time? It's been ten days and the situation hasn't changed(0) 讚! | 云来啸垄 |
作者: 風見浩岚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-06-29 14:32:28 評論於 This is not bad, you can give it a try(0) 讚! | 風見浩岚 |
作者: 風見浩岚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-06-29 12:34:23 評論於 4.489 points!(0) 讚! | 風見浩岚 |
作者: 岭南哲思 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-11-20 18:16:58 評論於 Have you invested recently? I have been working on stem cell research recently and I'm interested in investing in this area. Do you have any advice, experts?(0) 讚! | 岭南哲思 |
作者: Vada 領域: 生物 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-11-09 15:12:37 評論於 It’s hard to keep Zone 2 again this year, and it’s too fast..(0) 讚! | Vada |
作者: 碧桃梓希 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-11-09 14:34:50 評論於 Review speed: 3.0 Experience sharing: It seems difficult to maintain Zone 2 this year, the points are dropping too fast(0) 讚! | 碧桃梓希 |
作者: 蒙德醉曼 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-01-17 17:29:05 評論於 The recent lab resources are all hydrological(0) 讚! | 蒙德醉曼 |
作者: 书生艳清 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-12-02 14:43:09 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Experience sharing: Submitted on October 25th; With editor on November 2nd; Under editor evaluation on November 4th (thought it would be desk reject and rejected immediately) But surprisingly, received major revision comments from the editor on November 21st, need to supplement some experiments, two reviewers' comments, very serious, and sharp points, all accurately pointed out the deficiencies in my experimental design, which is also the soft spot I was afraid of before submission. Admit it. Try to supplement a little and strive for good luck again! The time given for major revision is 3 months(0) 讚! | 书生艳清 |
作者: 一条小雅秀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-10-25 15:24:18 評論於 Review Speed: 1.0 | Submission Acceptance Rate: 50.0 Sharing Experience: Submitted for two weeks and got rejected, the editor didn't say much, just said it wasn't suitable for their magazine(0) 讚! | 一条小雅秀 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-10-16 15:51:13 評論於 The submission was rejected without review after 3 days, and the comments from the editor were very harsh, almost questioning the entire article. I wonder if this journal has some prejudice against articles from China. It is indeed difficult to get accepted, although the quality of the other published articles in this journal is not particularly high. Their experimental approach is very similar to ours, just in a different direction. I hope everyone will be cautious when submitting their work, as it can easily dent your confidence(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-08-16 15:32:22 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Experience sharing: Stem cell research has been very popular recently. As long as the topic is innovative and well justified, it is relatively easy to get accepted. However, in the past two years, the impact factor of stem cell research has taken a dive, which is a bit unfortunate. This may be related to the increase in the number of articles accepted from China. We hope to revive and quickly raise the impact factor(0) 讚! | 凌霄高洁 |
作者: 努力啊大佳惠 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-07-30 18:13:30 評論於 3.912, continue diving(0) 讚! | 努力啊大佳惠 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-08-06 08:43:21 評論於 Not easy to get accepted, rejection rate is high. I finally got one published after a review process of 5 months(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-30 16:05:11 評論於 In 2010, it was 3.388, and in 2009, it was 3.368(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 16:12:47 評論於 Bullish, if it rises a bit more tomorrow, it may break through 3 points(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us